Literature DB >> 23628802

Regulation of TNF-α with a focus on rheumatoid arthritis.

Eva A V Moelants1, Anneleen Mortier, Jo Van Damme, Paul Proost.   

Abstract

Cytokines and chemokines represent two important groups of proteins that control the human immune system. Dysregulation of the network in which these immunomodulators function can result in uncontrolled inflammation, leading to various diseases including rheumatoid arthritis (RA), characterized by chronic inflammation and bone erosion. Potential triggers of RA include autoantibodies, cytokines and chemokines. The tight regulation of cytokine and chemokine production, and biological activity is important. Tumor necrosis factor-α (TNF-α) is abundantly present in RA patients' serum and the arthritic synovium. This review, therefore, discusses first the role and regulation of the major proinflammatory cytokine TNF-α, in particular the regulation of TNF-α production, post-translational processing and signaling of TNF-α and its receptors. Owing to the important role of TNF-α in RA, the TNF-α-producing cells and the dynamics of its expression, the direct and indirect action of this cytokine and possible biological therapy for RA are described.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23628802     DOI: 10.1038/icb.2013.15

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  52 in total

Review 1.  Innate lymphoid cells in autoimmunity: emerging regulators in rheumatic diseases.

Authors:  Medya M Shikhagaie; Kristine Germar; Suzanne M Bal; Xavier Romero Ros; Hergen Spits
Journal:  Nat Rev Rheumatol       Date:  2017-02-02       Impact factor: 20.543

2.  A Study of TNF Pathway Activation in Schizophrenia and Bipolar Disorder in Plasma and Brain Tissue.

Authors:  Eva Zsuzsanna Hoseth; Thor Ueland; Ingrid Dieset; Rebecca Birnbaum; Joo Heon Shin; Joel Edward Kleinman; Thomas Michael Hyde; Ragni Helene Mørch; Sigrun Hope; Tove Lekva; Aurelija Judita Abraityte; Annika E Michelsen; Ingrid Melle; Lars Tjelta Westlye; Torill Ueland; Srdjan Djurovic; Pål Aukrust; Daniel R Weinberger; Ole Andreas Andreassen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 3.  Regulation of tumour necrosis factor signalling: live or let die.

Authors:  Dirk Brenner; Heiko Blaser; Tak W Mak
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

4.  Structural basis for tumor necrosis factor blockade with the therapeutic antibody golimumab.

Authors:  Masatsugu Ono; Shoichiro Horita; Yumi Sato; Yayoi Nomura; So Iwata; Norimichi Nomura
Journal:  Protein Sci       Date:  2018-04-17       Impact factor: 6.725

5.  Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients.

Authors:  Catarina Addobbati; Heidi Lacerda Alves da Cruz; José Eduardo Adelino; Amanda Luíze Melo Tavares Ramos; Thiago Sotero Fragoso; Alexandre Domingues; Ângela Luiza Branco Pinto Duarte; Renê Donizeti Ribeiro Oliveira; Paulo Louzada-Júnior; Eduardo Antônio Donadi; Alessandra Pontillo; Jaqueline de Azevêdo Silva; Sergio Crovella; Paula Sandrin-Garcia
Journal:  Inflamm Res       Date:  2017-12-11       Impact factor: 4.575

6.  Safety and efficacy of intra-articular anti-tumor necrosis factor α agents compared to corticosteroids in a treat-to-target strategy in patients with inflammatory arthritis and monoarthritis flare.

Authors:  Francesco Carubbi; Luigi Zugaro; Paola Cipriani; Armando Conchiglia; Lorenzo Gregori; Cristino Danniballe; Maria Letizia Pistoia; Vasiliki Liakouli; Piero Ruscitti; Francesco Ciccia; Giovanni Triolo; Carlo Masciocchi; Roberto Giacomelli
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-18       Impact factor: 3.219

7.  Vitamin D receptor polymorphisms and expression profile in rheumatoid arthritis Brazilian patients.

Authors:  Catarina Addobbati Jordão Cavalcanti; Jaqueline de Azevêdo Silva; Will de Barros Pita; Tiago Degani Veit; Odirlei Andre Monticielo; Ricardo Machado Xavier; João Carlos Tavares Brenol; Cleiton Viegas Brenol; Thiago Sotero Fragoso; Alexandre Domingues Barbosa; Ângela Luiza Branco Pinto Duarte; Renê Donizeti Ribeiro Oliveira; Paulo Louzada-Júnior; Eduardo Antônio Donadi; Sergio Crovella; José Artur Bogo Chies; Paula Sandrin-Garcia
Journal:  Mol Biol Rep       Date:  2015-12-19       Impact factor: 2.316

8.  Shikonin inhibits TNF-α production through suppressing PKC-NF-κB-dependent decrease of IL-10 in rheumatoid arthritis-like cell model.

Authors:  Wen-Xiao Sun; Yan Liu; Wei Zhou; He-Wei Li; Jian Yang; Zhen-Bing Chen
Journal:  J Nat Med       Date:  2016-12-09       Impact factor: 2.343

9.  Early detection of hepatocellular carcinoma co-occurring with hepatitis C virus infection: A mathematical model.

Authors:  Abdel-Rahman Nabawy Zekri; Amira Salah El-Din Youssef; Yasser Mabrouk Bakr; Reham Mohamed Gabr; Ola Sayed Ahmed; Mostafa Hamed Elberry; Ahmed Mahmoud Mayla; Mohamed Abouelhoda; Abeer A Bahnassy
Journal:  World J Gastroenterol       Date:  2016-04-28       Impact factor: 5.742

Review 10.  Biologics for the treatment of autoimmune renal diseases.

Authors:  Stephen R Holdsworth; Poh-Yi Gan; A Richard Kitching
Journal:  Nat Rev Nephrol       Date:  2016-03-07       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.